Postmortem examination of 22 pancreatic carcinoma patients treated with helium ion irradiation.
Postmortem findings are available in this report in 22 patients with pancreatic carcinoma treated with helium ions at Lawrence Berkeley Laboratory; California. This represents the largest group evaluated histologically in the literature and is the first report evaluating effects of particle radiation in pancreatic tissue. Patient survival after therapy averaged 9 months. Most died of infection and/or pulmonary emboli. Local control was achieved in 27%. The pancreatic tumors had histologically more severe radiation changes than nontumor bearing pancreas. Irradiated bone marrow was severely hypocellular, and irradiated skin was atrophic. Five patients had radiation injury in the gastrointestinal tract. The spinal cord, liver, and kidneys showed no damage. This study demonstrates the safety of helium particle irradiation with present therapeutic planning. Injury to tumor was seen without excessive damage to adjacent tissues.
D000328:Adult; D000368:Aged; D001853:Bone Marrow / Q000528:radiation effects; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000532:radiotherapy*; D004064:Digestive System / Q000528:radiation effects; D005260:Female; D006371:Helium; D006801:Humans; D007477:Ions; D008297:Male; D008875:Middle Aged; D010179:Pancreas / Q000528:radiation effects; D010190:Pancreatic Neoplasms / Q000532:radiotherapy*; D010315:Particle Accelerators; D011832:Radiation Injuries / Q000473:pathology; D011882:Radiotherapy, High-Energy / Q000009:adverse effects*; D012867:Skin / Q000528:radiation effects
D007477:Ions; D006371:Helium